3Stubbs MT, Bode W. A player of many parts: the spotlight falls on thrombin' s structure. Thromb Res, 1993, 69:1-58.
4Weitz JI, Buller HR. Direct thrombin inhibitors in acute coronary syndromes:present and future. Circulation, 2002, 105 (8): 1 004-011.
5Organisation to Access Strategies for Ischaemic Syndromes (OASIS-2) Invesligators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction,refractory angina,and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial. Lancet, 1999, 353:429-438.
6Antman EM. Hirudin in acute myocardial infarction: safety report from the thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9A trial.Circulation, 1994, 90:1 624-642.
7Neuhaus KL, von Essen R, Tebbe U, Jessel A, Heinrichs H, Maurer W, et al. Safety observation from the pilot phrase of the randomized r-Hirudin for improvement of thrombolysis (HIT- Ⅲ)study:a study of the Arbeitsgemeinschaft Leitender Kardiologscher Krankenhausarzte. Circulation, 1994, 90: 1 638-642.
8The Global Use of Strategies to Open Occluded Arteries (GUSTO) Ⅱb Investigators. A comparison of recombinant hirodin with heparin for the treatment of acute coronary syndromes. N Engl J Med, 1996, 335:775-782.
9Antman EM. Hirudin in acute myocagdial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation, 1996, 94:911-921.
10Seruys PW, Hemman JP, Simon R, Rutsch W, Bode C, Lamman GJ, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helivetica investigator. N Engl J Med, 1995, 333:757-763.
7Payson R A, Canatan H, Chotani M A, et al. Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA [J].Nucleic Acids Res, 1993,21(3) :489- 495.
8Forough R, Wang X, Martinez Lemus L A, et al. Cell-based and direct gene transfer-induced angiogenesis via a secreted chimeric fibroblast growth factor 1 (sp-FGF-1) in the chick chorioallantoic membrane (CAM)[J]. Angiogenesis, 2003,6(1) :47-54.
9Linder V, Lappi D A, Bair A. et al. Role of fibroblast growth factor in vascular lesion formation[J]. Circ Res, 1991, 68:106-113.
10Lindner V, Majack R A, Reidy M A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries [J ]. J Clin Invest, 1990,85 (6) : 2004-2008.